Treatment Registry
TR-0547 ActiveRecorded September 2, 2026Last verified September 3, 2026

Oral semaglutide

Sold by VirtualCare2Go · Oral tablet · every oral semaglutide record

What you actually pay

First month

$698.99

Every month after

$599

Medication · Weight Loss Tablets — 1 month supply$599
Consultation fee · first month only$99.99

Added from the figures recorded below.

Price

TermPer monthCharged today
Weight Loss Tablets — 1 month supply

Weight Loss Tablets $599 Semaglutide medication, consultation, and shipping included

source, read September 2, 2026

Per month$599Charged today$599
Visit VirtualCare2Go

We earn nothing from this link. VirtualCare2Go has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

  1. September 2, 2026$599
  2. September 3, 2026$599
  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberLive visit
Cancellation“You can cancel your appointment for a full refund if you cancel at least 24 hours in advance.”
Consult fee$99.99. Self-Pay: $99.99 per visit, anytime any day. A membership at $167 per month (billed annually) is offered as the alternative, and it covers unlimited virtual care.

Not yet checked: pharmacy, states and membership.

Recorded from virtualcare2go.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The $629 'Weight Loss Injections' tier covers Semaglutide, Liraglutide OR Tirzepatide at one price without saying which drug applies to which packaging ('Prescription pen or vial'), so it is recorded as unspecified GLP-1 with form not-disclosed rather than assigned to one drug. The separate $99.99 option is explicitly a consultation-only fee that excludes medication cost, so it is recorded under membership, not prices, matching the brief's rule. There is also a separate, unrelated general '1Care2Go' urgent-care membership at $167/mo — that is not specific to the weight-loss program and is not recorded.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0547
Readings
2

Related records

What else VirtualCare2Go sells

All VirtualCare2Go programs and terms

Oral semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 55 records of the same molecule.

Cite this entry

Treatment Registry. (2026). VirtualCare2Go oral semaglutide (TR-0547). Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0547

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.